ACET vs BMRN · $75.7M cap vs P/E 40, rev $2.85B
Adicet Bio Inc (ACET) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
ACET does not have a complete income-statement cache yet.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ACET currently screens at market cap $75.7M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ACET and BMRN stock pages for the full models.
Not investment advice.